Cellyan Biotechnology Co Ltd Class A HKPD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.45
- Day Range
- $0.43–0.44
- 52-Week Range
- $0.32–2.58
- Bid/Ask
- $0.37 / $0.55
- Shares Outstanding
- 23.50M
- Market Cap
- $10.12M
- Volume/Avg
- 71 / 364,274
Key Statistics
- Price/Earnings (Normalized)
- 271.61
- Price/Sales
- 0.27
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 27
- Website
- http://www.9zt.hk
Valuation
|
Metric
|
HKPD
|
|---|---|
Price/Earnings (Normalized) | 271.61 |
Price/Book Value | 0.92 |
Price/Sales | 0.27 |
Price/Cash Flow | 11.02 |
Price/Earnings
HKPD
Financial Strength
|
Metric
|
HKPD
|
|---|---|
Quick Ratio | 2.51 |
Current Ratio | 2.93 |
Interest Coverage | −5.94 |
Quick Ratio
HKPD
Profitability
|
Metric
|
HKPD
|
|---|---|
Return on Assets (Normalized) | −7.05% |
Return on Equity (Normalized) | −13.30% |
Return on Invested Capital (Normalized) | −7.82% |
Return on Assets
HKPD
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|h>GGZl | LOCK|YT@Z> | $95B | |||
| Cencora Inc
COR
| LOCK|V^cTBX | LOCK|Sbl^ | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|Y<?j<c | LOCK|s?Zw% | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|>ww% | $23B | |||
| Henry Schein Inc
HSIC
| LOCK|L?ypZ! | LOCK|HXH^z | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|Ysl | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|NHQ | $7B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|&Q& | $7B | |||
| Medipal Holdings Corp ADR
MAHLY
| — | LOCK|T!V | $3B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|#! | $3B |
United States